← Research.Patient.info
Browse research by treatment
1,000 treatments and interventions are being studied right now — from new medicines to therapies, devices and lifestyle programmes.
- Placebo6531114
- Pembrolizumab104204
- Carboplatin65136
- Cisplatin52111
- Paclitaxel38101
- Dexamethasone4381
- Cyclophosphamide4180
- Durvalumab3078
- Gemcitabine4074
- Nivolumab3172
- Bevacizumab4068
- Rituximab2865
- Atezolizumab2265
- Docetaxel2864
- Pemetrexed2764
- No Intervention4755
- Lenalidomide1955
- Capecitabine2550
- Oxaliplatin2547
- Doxorubicin2747
- Prednisone2244
- Standard of care2542
- blood sample3038
- MRI3137
- Nab-paclitaxel1637
- Questionnaires3237
- Venetoclax1937
- Daratumumab1836
- Biospecimen Collection1936
- Magnetic Resonance Imaging2034
- Fulvestrant1633
- Fludarabine1733
- Olaparib1132
- Pomalidomide1732
- Bortezomib1331
- Radiotherapy1531
- Enzalutamide1430
- Etoposide1430
- Cetuximab1930
- Obinutuzumab1630
- Vincristine1630
- Irinotecan1629
- Tocilizumab1729
- Radiation Therapy1328
- Questionnaire2628
- Abemaciclib1227
- Letrozole1327
- Temozolomide1527
- Trastuzumab1326
- Leucovorin1626
- Computed Tomography1125
- Palbociclib1024
- Blood sampling2224
- Exercise1824
- Trastuzumab Deruxtecan1524
- Usual Care1823
- Everolimus1123
- Ribociclib1422
- Control1422
- Ruxolitinib1022
- Cabozantinib821
- Questionnaire Administration921
- Epcoritamab521
- Quality-of-Life Assessment721
- Semaglutide720
- Fluorouracil1020
- Dostarlimab720
- Sacituzumab tirumotecan1420
- Azacitidine820
- Data Collection1619
- Acalabrutinib819
- Ipilimumab919
- Cytarabine919
- Lenvatinib519
- Rilvegostomig1619
- Risankizumab918
- Cemiplimab718
- Inavolisib1018
- Amivantamab918
- Exemestane1018
- Carfilzomib1018
- Laboratory Biomarker Analysis218
- Bendamustine1018
- Teclistamab817
- Baricitinib917
- Tirzepatide1017
- Osimertinib316
- Observation1216
- Tremelimumab516
- 5-Fluorouracil1216
- Niraparib516
- Pumitamig1616
- Dupilumab616
- Anastrozole816
- Zanubrutinib716
- Upadacitinib816
- Topotecan916
- Prednisolone1116
- Avelumab415
- Trametinib615
- Guselkumab415
- Chemotherapy815
- Methotrexate715
- Abiraterone acetate514
- Sunitinib714
- Midazolam714
- Belzutifan514
- Methylprednisolone614
- Pirtobrutinib713
- Blood samples1113
- Talquetamab713
- Rescue Medication1313
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.13
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.13
- Glofitamab713
- Ibrutinib513
- Vinorelbine613
- Control Group1012
- Bimekizumab412
- KEYTRUDA 25 mg/mL concentrate for solution for infusion12
- Mirikizumab812
- Ocrelizumab212
- Apalutamide312
- Elranatamab912
- Positron Emission Tomography812
- Tamoxifen612
- Abiraterone711
- biopsy911
- Metformin311
- Blood test1111
- Capivasertib411
- Matching Placebo811
- Darolutamide711
- Biopsy Procedure511
- Deucravacitinib411
- Surgery610
- Entrectinib310
- Eribulin310
- ifosfamide710
- Placebo Administration410
- Giredestrant410
- Pertuzumab410
- standard care710
- Orforglipron510
- Volrustomig710
- IMVT-1402810
- Sonrotoclax710
- Belantamab mafodotin410
- Dacarbazine410
- Ustekinumab310
- Tacrolimus510
- Sotorasib39
- Observational79
- Bone Scan79
- Alectinib49
- Sample collection99
- Polatuzumab vedotin49
- Radiation59
- Virtual Reality79
- Anakinra69
- Placebo oral tablet59
- Empagliflozin79
- Adagrasib79
- FOLFOX89
- Iberdomide59
- tucatinib39
- Filgotinib59
- Dato-DXd49
- Nipocalimab69
- KarXT99
- Isatuximab59
- Adalimumab39
- Selinexor19
- Retatrutide29
- Alpelisib28
- No Intervention: Observational Cohort88
- Luspatercept48
- Tezepelumab38
- normal saline78
- Rescue Medications58
- Saline68
- Efgartigimod PH20 SC48
- Pulmonary vein isolation78
- Tislelizumab58
- Panitumumab78
- Sacituzumab Govitecan58
- ianalumab38
- Iptacopan48
- Afimkibart68
- Not applicable (observational study)88
- Enfortumab Vedotin28
- Odronextamab68
- Tarlatamab28
- Blinatumomab78
- Echocardiography Test68
- Multigated Acquisition Scan58
- Psilocybin58
- SBRT48
- IMFINZI 50 mg/mL concentrate for solution for infusion.8
- Apixaban48
- Dasatinib38
- Cagrilintide28
- Ramucirumab38
- Datopotamab Deruxtecan17
- Tulisokibart27
- Hydrocortisone37
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.7
- Echocardiogram77
- Lumbar puncture67
- MRI scan57
- PET-MRI67
- Teriflunomide17
- Bariatric surgery67
- Biological collection77
- Blood sample collection77
- Atogepant37
- Secukinumab17
- Trifluridine/Tipiracil47
- Cognitive assessment67
- Diet77
- Sham (No Treatment)77
- Stereotactic Ablative Radiotherapy37
- ADT17
- Rilzabrutinib47
- zanidatamab67
- Platinum based chemotherapy37
- Cardiac MRI47
- Deucrictibant67
- Busulfan57
- LHRH Agonist17
- Linvoseltamab77
- Mitapivat7
- Corticosteroids37
- Divarasib47
- Questionnaire and Physical Exam77
- Temozolomide (TMZ)57
- NNC0487-011177
- Lazertinib27
- Inclisiran57
- Folinic acid47
- Encorafenib37
- Amlitelimab27
- Zimberelimab17
- Tiragolumab27
- Sonelokimab27
- Rivaroxaban47
- AZD139066
- Ipatasertib26
- PREHABILITATION56
- Lutikizumab16
- Sparsentan46
- Non Interventional46
- Routine care66
- Transcranial Direct Current Stimulation56
- Trastuzumab emtansine16
- Cetrelimab16
- Lebrikizumab16
- Neuropsychological tests56
- Pemetrexed/Carboplatin16
- Standard treatment56
- vincristine sulfate6
- 5-fluorouracil (5-FU)66
- Amoxicillin26
- Belimumab46
- benralizumab36
- binimetinib46
- Exercise Training66
- FOLFIRI66
- levoleucovorin36
- Pembrolizumab (KEYTRUDA®)46
- Sham procedure36
- Standard of Care (SOC)46
- Breath test56
- Venepuncture46
- Gemcitabine + cisplatin16
- riliprubart46
- Camizestrant56
- Frexalimab36
- Patritumab deruxtecan46
- Surovatamig66
- APG77736
- Risdiplam56
- 5-FU16
- Saruparib36
- Sacituzumab Govitecan-hziy26
- Azacitidine (AZA)56
- Remibrutinib26
- Aspirin46
- Bone Marrow Aspiration26
- Mosunetuzumab56
- Melphalan46
- JNJ-772421136
- Inulin66
- Intensity-Modulated Radiation Therapy26
- Ezabenlimab16
- Elotuzumab46
- Domvanalimab26
- Dexmedetomidine56
- Crizotinib26
- Ceralasertib26
- Zilovertamab vedotin56
- Vinblastine46
- Vedolizumab56
- Stereotactic Body Radiotherapy36
- Elacestrant45
- Sham35
- Exercise Intervention45
- Pemetrexed/Cisplatin15
- Depemokimab35
- Colonoscopy55
- Liver biopsy45
- Non-Interventional Study45
- radical prostatectomy15
- Saliva sample25
- Smartwatch45
- Time-restricted eating55
- Brentuximab Vedotin35
- Dietary Intervention35
- Interview45
- Mitomycin c25
- Physiotherapy45
- Placebo tablet35
- Quality of life questionnaires35
- AZD090135
- Urine sample35
- Vehicle Cream45
- AZD98335
- Whey Protein55
- Aerobic exercise45
- Magnetic Resonance Imaging (MRI)55
- Photobiomodulation55
- placebo capsule25
- vicadrostat45
- Zongertinib35
- Dapagliflozin35
- Golcadomide35
- Ravulizumab25
- Relatlimab35
- Sotatercept35
- Telisotuzumab adizutecan45
- Mycophenolate Mofetil55
- Prednisone/prednisolone45
- Barzolvolimab25
- Lunsekimig45
- Maridebart cafraglutide35
- Route of administration: Oral use5
- XBD17355
- Furmonertinib5
- Momelotinib55
- Ketamine Hydrochloride45
- Intismeran autogene25
- Lecanemab5
- Nivolumab + Relatlimab45
- Placebo IV35
- Supportive care measures35
- Observational study55
- Obexelimab15
- Selumetinib15
- Zanzalintinib45
- Capmatinib35
- Cobimetinib15
- Patient Observation25
- Placebo (matched to NNC0487-0111)55
- Radiofrequency ablation45
- Stereotactic Body Radiation Therapy15
- Ultrasound35
- Active Surveillance35
- Bone Marrow Biopsy15
- Brachytherapy25
- Calderasib55
- Oleclumab15
- Norepinephrine55
- Nerandomilast55
- Mavacamten25
- KarX-EC55
- indocyanine green35
- Futibatinib45
- Felzartamab35
- CEFAZOLIN35
- Botulinum toxin type A15
- Bleomycin15
- 177Lu-PSMA-61725
- Ritlecitinib15
- Regorafenib25
- BCG24
- Sodium Chloride24
- Transcranial direct current stimulation (tDCS)44
- Nilotinib14
- Aortic valve replacement34
- Prostate biopsy14
- Ofatumumab24
- givinostat34
- Gemcitabine + carboplatin4
- Fianlimab4
- Skin biopsy34
- Tranexamic Acid44
- Belrestotug4
- blood draw34
- Dabrafenib24
- Mepolizumab4
- Non-invasive ventilation34
- Placebo semaglutide14
- Placebo supplement34
- Androgen Deprivation Therapy (ADT)24
- anvumetostat4
- Biofeedback training44
- Blood collection34
- Catheter ablation24
- CGT948644
- Conduction System Pacing44
- Emicizumab24
- goserelin24
- No interventions.44
- Percutaneous coronary intervention34
- Placebos44
- Protein supplement34
- Quality of Life44
- AZD530524
- Treatment as Usual (TAU)34
- garadacimab4
- LEUCOVORIN CALCIUM4
- BGB-1141734
- Lung ultrasound44
- psilocybin (25 mg)44
- stereotactic body radiotherapy (SBRT)34
- Bleximenib34
- Blood tests44
- SYT-51044
- Glucose24
- daraxonrasib44
- Epoetin alfa24
- Bulevirtide24
- Cabazitaxel34
- Rapcabtagene autoleucel34
- Remdesivir44
- Sacituzumab govitecan-hziy (SG)14
- Revumenib34
- Transthoracic echocardiography44
- Elecoglipron44
- Electrocardiogram34
- Icotrokinra34
- Imlunestrant14
- povorcitinib14
- survodutide24
- Aflibercept14
- Transthoracic echocardiogram34
- BHV-700024
- CTX00124
- Inebilizumab34
- zolbetuximab24
- disitamab vedotin14
- Ifinatamab Deruxtecan34
- Datopotamab deruxtecan (Dato-DXd)44
- Ivosidenib44
- DOR/ISL4
- Efgartigimod IV34
- Finerenone (Kerendia, BAY94-8862)44
- Nemolizumab14
- Idelalisib24
- Nirogacestat14
- Itepekimab (SAR440340)14
- Nemtabrutinib34
- Opevesostat44
- Paltusotine14
- Pegcetacoplan24
- Pembrolizumab (+) Berahyaluronidase alfa24
- Pembrolizumab/Quavonlimab4
- Placebo for Atogepant14
- RO72042394
- Rucaparib14
- Saline Nasal Spray44
- Satralizumab24
- T-DXd24
- RCT210044
- TAR-2004
- Vemurafenib14
- Venetoclax (VEN)34
- [177Lu]Lu-NeoB24
- [68Ga]Ga-NeoB24
- Sorafenib4
- Selpercatinib4
- BGB-1667344
- Claseprubart34
- Elritercept44
- golexanolone34
- MEDI47364
- Placebo Comparator34
- Plozasiran Injection14
- Tafasitamab4
- Tebentafusp24
- Vosoritide24
- XEN110134
- [177Lu]Lu-DOTA-TATE14
- AAA61734
- Belumosudil34
- Brenipatide44
- BMS-98650444
- Chemotherapy drug44
- Cilta-cel4
- Daunorubicin34
- Dactinomycin24
- Efanesoctocog alfa34
- Etentamig34
- Mitapivat-matching placebo4
- Pegaspargase14
- Repetitive Transcranial Magnetic Stimulation (rTMS)44
- RPT90444
- Optimal Medical Therapy24
- OPDIVO 10 mg/mL concentrate for solution for infusion.4
- Monalizumab14
- Lurbinectedin14
- Lutathera24
- Tecentriq 1 200 mg concentrate for solution for infusion4
- Escitalopram34
- INZ-70134
- Imatinib34
- Forxiga 10 mg film-coated tablets4
- Enoxaparin24
- education34
- ECG44
- Degarelix14
- Colchicine34
- Cemdisiran24
- Budigalimab34
- ASTX72724
- Azithromycin34
- Apremilast34
- YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.4
- visugromab (CTL-002)34
- Transcranial Magnetic Stimulation24
- Tepotinib14
- Tazemetostat14
- Standard Care (in control arm)44
- Sirolimus34
- Rapamune 1 mg/mL oral solution4
- Ranibizumab14
- Pozelimab24
- Electroencephalogram (EEG)33
- H2 receptor antagonist23
- MORPHINE23
- Placebo Control33
- Radiprodil13
- Standard medical treatment33
- Waitlist33
- Microcrystalline Cellulose33
- clinical examination33
- Repetitive Transcranial Magnetic Stimulation33
- Total knee arthroplasty23
- PIT56523
- PF-0786848913
- Neuropsychological Assessment33
- Acalabrutinib (ACP-196)3
- Intervention23
- Encorafenib + Binimetinib3
- Electrical stimulation33
- Cardiac Magnetic Resonance Imaging33
- Remote Monitoring13
- Standard of care treatment23
- Telephone follow-up33
- adjuvant therapy3
- Trastuzumab deruxtecan (T-DXd)23
- Biological samples33
- biological sampling33
- cochlear implantation23
- Edoxaban13
- Electrical Impedance Tomography13
- FARAPULSE™ Pulsed Field Ablation System3
- Imaging23
- AloCelyvir3
- KEYTRUDA®13
- Maltodextrin33
- multiparametric MRI23
- NaCl (0,9%)33
- ALXN18503
- Omnipod 533
- Physical activity33
- positron emission tomography (PET)33
- Povetacicept13
- Sham Control33
- [68Ga]FAPI-463
- Amino-Acid Solution13
- Axatilimab13
- dapansutrile23
- ECG monitoring13
- EEG23
- Empagliflozin 10 mg33
- FLOT Chemotherapy23
- Flow cytometry33
- fruquintinib33
- Fenebrutinib3
- Implantable loop recorder23
- Litifilimab13
- Moxifloxacin33
- Fingolimod3
- Nuwiq33
- Pelvic Floor Muscle Training33
- Placebo Injection23
- Placebo mouthwash33
- Quality of life questionnaire23
- Registry33
Showing the top 600 of 1,000 matches — refine your search to narrow down.